摘要
本文应用 rIL-2体外诱导自身 LAK(Lynphokine-Activated Killing)细胞,对眼部恶性肿瘤病人进行瘤区局部治疗,取得较好的疗效,16例恶性肿瘤中,基底细胞癌5例;完全消退4例,部分消退1例,睑板腺癌4例,鳞状细胞癌2例,视网膜母细胞瘤,眶内非何杰金氏淋巴瘤,眶内血管外皮瘤,眶内纤维组织细胞瘤(生长活跃),汗腺癌各1例,都获完全消退.以上结果表明,病人自身 LAK 细胞局部治疗是一种有效的免疫方法.眼科学报 1993;9:51-54。
In this paper,the authors reported the method of treating ocular malignant tumors with
lymphokine-activated killing cells which were induced by rIL-2 in vitro.Among the sixteen cases of ocu-
lar tumors,4 cases of 5 base cell carcinoma(1 case of which was partially extinctive),4 cases of tarsal
gland carcinoma,2 cases of squamous cell carcinoma and respectively 1 case of retinoblastoma,non-
Hodykin's lymphoma,intraobital hemangiopericytoma,intraobital fibrous histiocytomas and hidradeno-
carcinoma were completely extinctive.The result shows that the immunotherapy method is effective.Eye
Science 1993;9:51-54.
出处
《眼科学报》
1993年第2期51-54,共4页
Eye Science
关键词
眼肿瘤
杀伤细胞
免疫疗法
lymphokine-activated killing(LAK) cell
ocular malignant tumor
immunotherapy
